The obese patient in the ICU

Chest

Volumn 113, Issue 2, 1998, Pages 492-498

  Marik, Paul ^a,c   Varon, Joseph ^b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c SAINT VINCENT HOSPITAL   (United States)

Author keywords

Cardiac; Complications; Drug dosing; ICU; Nutrition support; Obesity; Pharmacokinetics; Pulmonary; Surgery

Indexed keywords

AMINOGLYCOSIDE; AMINOPHYLLINE; BENZODIAZEPINE DERIVATIVE; CARBON DIOXIDE; CHOLESTEROL; CREATININE; CYCLOSPORIN; DIGOXIN; FATTY ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; LIPOPROTEIN; LORAZEPAM; METHYLPREDNISOLONE; NEUROMUSCULAR BLOCKING AGENT; OROSOMUCOID; OXYGEN; PLASMA PROTEIN; PROPRANOLOL; QUINOLONE DERIVATIVE; SUFENTANIL; THEOPHYLLINE; TRIACYLGLYCEROL; VERAPAMIL;

ASPIRATION PNEUMONIA; BODY MASS; CALORIMETRY; CREATININE CLEARANCE; CRITICAL ILLNESS; DRUG DISTRIBUTION; DRUG METABOLISM; ENDOTRACHEAL INTUBATION; ENERGY EXPENDITURE; GLOMERULUS FILTRATION RATE; HEART FUNCTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART OUTPUT; HUMAN; INTENSIVE CARE UNIT; LIPOPHILICITY; LUNG EMBOLISM; LUNG FUNCTION; NUTRITIONAL SUPPORT; OBESITY; PRIORITY JOURNAL; RESPIRATORY FAILURE; REVIEW; RISK FACTOR; THROMBOEMBOLISM; VASCULAR ACCESS;

EID: 0031912062     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.113.2.492     Document Type: Article

References (86)

1. Health implications of obesity: National Institutes of Health Consensus Development Conference Statement. Ann Intern Med 1985; 103:147-51
2. Anonymous. Update: prevalence of overweight among children, adolescents and adults - United States 1988-1994. MMWR Morb Mortal Wkly Rep 1997; 46:198-202
3. Lew EA, Garfinkel L. Variations in mortality by weight among 750,000 men and women. J Chronic Dis 1979; 32:563-76
4. Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960-1991. JAMA 1994; 272:205-11
5. Williamson DF. Descriptive epidemiology of body weight and weight change in US adults. Ann Intern Med 1993; 119:646-49
6. Kral JK, Heymsfield S. Morbid obesity: definitions, epidemiology, and methodological problems. Gastroenterol Clin North Am 1987; 16:197-205
7. Horton ES. Obesity. In: Stein JH, ed. Internal medicine. St. Louis: Mosby, 1994; 1263-66
8. Najjar MF, Rowland M. Anthropometric reference data and prevalence of overweight, United States, 1976-1980. Vital and health statistics, series 11, No. 238. DHHS publication No.(PHS) 87-1688. Washington, DC: Public Health Service, 1987
9. VanItalie TB. Prevalence of obesity. Endocrinol Metab Clin North Am 1996; 25:887-905
10. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-28
11. Knaus WA, Wagner DP, Draper EA, et al. The APACHE III prognostic system: risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-36
12. Smith-Choban P, Weireter LJ, Maynes C. Obesity and increased mortality in blunt trauma. J Trauma 1991; 31:1253-57
13. Rose DK, Cohen MM, Wigglesworth DF, et al. Critical respiratory events in the postanesthesia care unit: patient, surgical and anesthetic factors. Anesthesiology 1994; 81: 410-18
14. Goldhaber SZ, Goldstein E, Stampfer ML, et al. A prospective study of risk factors for pulmonary embolism in women. JAMA 1997; 277:642-45
15. Ray C, Sue D, Bray C, et al. Effects of obesity on respiratory function. Am Rev Respir Dis 1983; 128:501-06
16. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function: the normative aging study. Chest 1997; 111:891-98
17. Douglas FG, Chong PY. Influence of obesity on peripheral airway patency. J Appl Physiol 1972; 33:559-63
18. Zerah F, Harf A, Perlemuter L, et al. Effects of obesity on respiratory resistance. Chest 1993; 103:1470-76
19. Vaughan RW, Conaham TJI. Part I: Cardiopulmonary consequences of morbid obesity. Life Sci 1980; 26:2119-27
20. Thomas PS, Cowen ERT, Hulands G, et al. Respiratory function in the morbidly obese before and after weight loss. Thorax 1989; 44:382-86
21. Collins LC, Hoberty PD, Walker JF, et al. The effect of body fat distribution on pulmonary function tests. Chest 1995; 107:1298-1302
22. Sue DY. Obesity and pulmonary function: more or less? Chest 1997; 111:844-45
23. Suratt P, Wilheit S, Hsiao H. Compliance of the chest wall in obese subjects. J Appl Physiol 1984; 57:403-09
24. Holley HS, Milic-Emili J, Becklake MR, et al. Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest 1967; 46:475-81
25. Drenick EJ, Fisler JS. Sudden cardiac arrest in morbidly obese surgical patients unexplained after autopsy. Am J Surg 1988; 155:720-26
26. Hedenstierna G. Gas exchange during anaesthesia. Br J Anaesth 1990; 64:507-14
27. Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994; 154: 1705-11
28. Burns SM, Egloff MB, Ryan B, et al. Effect of body position on spontaneous respiratory rate and tidal volume in patients with obesity, abdominal distension and ascites. Am J Crit Care 1994; 3:102-06
29. Vaughan RW, Bauer S, Wise L. Volume and pH of gastric juice in obese patients. Anesthesiology 1975; 43:686-89
30. Agarwal N, Shibutani K, San Filippo JA. Hemodynamic and respiraton changes in surgery of the morbidly obese. Surgery 1982; 92:226-33
31. Pasulka PS, Bistrian BR, Benotti PN. The risks of surgery in obese patients. Ann Intern Med 1986; 104:540-46
32. Strauss RJ, Wise L. Operative risks of obesity. Surg Gynecol Obstet 1978; 146:286-91
33. Vaughan RW, Wise L. Postoperative arterial blood gas measurement in obese patients: effects of position on gas exchange. Ann Surg 1975; 182:705-09
34. Vaughan RW, Wise L. Intra-operative arterial oxygenation in obese patients. Ann Surg 1976; 184:35-42
35. Gass GD, Olsen GN. Preoperative pulmonary function testing to predict postoperative morbidity and mortality. Chest 1986; 89:127-35
36. Clayton JK, Anderson JR, McNicol GP. Preoperative prediction of postoperative deep vein thrombosis. BMJ 1976; 2:910-12
37. Kakkar VV, Howe CT, Nicolaides AN, et al. Deep vein thrombosis of the leg: is there a 'high-risk' group. Am J Surg 1970; 120:527-30
38. Bern MM, Bothe AJ, Bistrian B, et al. Effects of low-dose warfarin on antithrombin III levels in morbidly obese patients. Surgery 1983; 94:78-83
39. Meilahn EN, Cauley JA, Tracy RP, et al. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women. Am J Epidemiol 1996; 143:159-66
40. Almer L, Janzon L. Low vascular fibrinolytic activity in obesity. Thromb Res 1975; 6:171-75
41. Williamson JA, Webb RK, Szekely S, et al. The Australian Incident Monitoring Study: difficult intubation: an analysis of 2,000 incident reports. Anaesth Intensive Care 1993; 21: 602-07
42. Backman L, Freyschuss U, Hallbert D, et al. Cardiovascular function in extreme obesity. Acta Med Scand 1983; 149: 437-39
43. De Divitiis O, Fazio S, Peteto M, et al. Obesity and cardiac function. Circulation 1981; 64:477-80
44. Rexrode KM, Manson JE, Hennekens CH. Obesity and cardiovascular disease. Curr Opin Cardiol 1996; 11:490-95
45. Alexander JK, Dennis DW, Smith WG, et al. Blood volume, cardiac output and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull 1962; 1:39-44
46. Nakajina T, Fujioka S, Tokunaga K, et al. Noninvasive study of left ventricular performance in obese patients: influence of duration of obesity. Circulation 1985; 71:481-86
47. Alpert MA, Singh A, Terry BE, et al. Effect of exercise on left ventricular systolic function and reserve in morbid obesity. Am J Cardiol 1989; 63:1478-82
48. Licata C, Scaglione R, Barbagallo M. Effect of obesity on left ventricular function studied by radionuclide angiocardiography. Int J Obes 1991; 15:295-302
49. Merlino G, Scaglione R, Carrao S, et al. Association between reduced lymphocyte beta-adrenergic receptors and left ventricular dysfunction in young obese subjects. Int J Obes Metab Disord 1994; 18:699-703
50. Merlino G, Scaglione R, Paterna S, et al. Lymphocyte beta-adrenergic receptors in young subjects with peripheral or central obesity: relationship with central haemodynamics and left ventricular function. Eur Heart J 1994; 15:786-92
51. Berkalp B, Cesur V, Corapcioglu D, et al. Obesity and left ventricular diastolic dysfunction. Int J Cardiol 1995; 52:23-26
52. Lauer MS, Anderson KM, Kannel WB, et al. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA 1991; 266:231-36
53. Abernethy DR, Greenblatt DL. Drug disposition in obese humans: an update. Clin Pharmacokinet 1986; 11:199-213
54. Cheymol G. Clinical pharmacokinetics of drugs in obesity: an update. Clin Pharmacokinet 1993; 25:103-14
55. Blouin RA, Kolpek JH, Mann HJ. Influence of obesity on drug disposition. Clin Pharm 1987; 6:706-14
56. Abernethy DR, Greenblatt DJ. Pharmacokinetics of drugs in obesity. Clin Pharmacokinet 1982; 7:108-24
57. Blonin RA, Chandler MH. Special pharmacokinetic consideration in the obese. In: Evan WE, Shentag JJ, Jusko WJ, eds. Applied pharmacokinetics: principles of therapeutic drug monitoring. 3rd ed. Spokane, Wash: Applied Therapeutics, 1992; Chapter 11, 1-20
58. Li L, Miles MV, Lakkis H, et al. Vancomycin-binding characteristics in patients with serious infections. Pharmacotherapy 1996; 16:1024-29
59. Zahorska-Markiewicz B, Waluga M, Zielinski M, et al. Pharmacokinetics of theophylline in obesity. Int J Clin Pharmacol Ther 1996; 34:393-95
60. Flechner SM, Kolbeinsson ME, Tam J, et al. The impact of body weight on cyclosporine pharmacokinetics in renal transplant recipients. Transplantation 1989; 47:806-10
61. Traynor AM, Nafziger AN. Aminoglycoside dosing weight correction factors for patients of various body sizes. Antimicrob Agents Chemother 1995; 39:545-48
62. Wasan KM, Lopex-Berestein G. The influence of serum lipoproteins on the pharmacokinetics and pharmacodynamics of lipophilic drugs and drug carriers. Arch Med Res 1993; 24:395-401
63. Suh B, Craig WA, England AC, et al. Effect of free fatty acids on the protein binding of antimicrobial agents. J Infect Dis 1981; 143:986-97
64. 1-acid glycoprotein levels. Ther Drug Monit 1995; 17:107-12
65. 1-acid glycoprotein in moderatley obese male subjects. Br J Clin Pharmacol 1984; 18:941-46
66. Anderson T, Gluud C. Liver morphology in morbid obesity: a literature study. Int J Obes 1984; 8:97-106
67. Caraco Y, Zylber-Katz E, Barry EM, et al. Antipyrine disposition in obesity: evidence for negligible effect of obesity on hepatic oxidative metabolism. Eur J Clin Pharmacol 1995; 47:525-30
68. Morgan DJ, Bray M. Lean body mass as a predictor of drug dosage: implications for drug therapy. Clin Pharmacokinet 1994; 26:292-307
69. Abernethy DR, Greenblatt DJ, Divoll M, et al. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen. J Lab Clin Med 1983; 101:873-80
70. Salazar DE, Corcoran GB. Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 1988; 84:1053-60
71. Stockholm KH, Brochner-Mortensen J, Hoilund-Carlson PF. Increased glomerular filtration rate and adrenocortical function in obese women. Int J Obes 1980; 4:57-63
72. Blouin RA, Bauer LA, Miller DD, et al. Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother 1982; 21:575-80
73. Snider RD, Kruse JA, Bander JJ, et al. Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit. Pharmacotherapy 1995; 15:747-53
74. Shikora SA, Muskat PC. Protein-sparing modified-fast total parenteral nutrition formulation for a critically ill morbidly obese patient. Nutrition 1994; 10:155-58
75. Ireton-Jones CS, Francis C. Obesity: nutrition support practice and application to critical care. Nutr Clin Pract 1995; 10:144-49
76. Jeevanandam M, Young DH, Schiller WR. Obesity and the metabolic response to severe multiple trauma in man. J Clin Invest 1991; 87:262-69
77. Jeevanandam M, Ramias L, Schiller WR. Altered plasma amino acid levels in obese traumatized man. Metabolism 1991; 40:385-90
78. Ireton-Jones CS, Turner WW. Actual or ideal body weight: which should be used to predict energy expenditure. J Am Diet Assoc 1991; 91:193-95
79. Makk LJK, McClave DSA, Creech PW. Clinical application of the metabolic cart to the delivery of total parenteral nutrition. Crit Care Med 1990; 18:1320-27
80. Burge JC, Goon A, Choban PS, et al. Efficacy of hypocaloric total parenteral nutrition in hospitalized obese patients: a prospective, double-blind randomized trial. JPEN J Parenter Enteral Nutr 1994; 18:203-07
81. Dickerson RN, Rosato EF, Mullen JL. Net protein anabolism with hypocaloric parenteral nutrition in obese stressed patients. Am J Clin Nutr 1986; 44:747-55
82. Gilbert TB, Seneff MG, Becker RB. Facilitation of internal jugular venous cannulation using an audio-guided Doppler ultrasound vascular access device: results from a prospective dual-center, randomized, crossover clinical study. Crit Care Med 1995; 23:60-65
83. Wilson AT, Reilly CS. Anesthesia and the obese patient. Int J Obes Metab Disord 1993; 17:427-35
84. Boulanger BR, Milzman DP, Rodriquez A. Obesity. Crit Care Clin 1994; 10:613-22
85. Gratz I, Afshar M, Kidwell P, et al. Doppler-guided cannulation of the internal jugular vein: a prospective randomized trial. J Clin Monit 1994; 10:185-88
86. Gallieni M, Cozzolino M. Uncomplicated central vein catheterization of high risk patients with real time ultrasound guidance. Int J Artif Organs 1995; 18:117-21